RecruitingPhase 2Phase 3NCT06643507
Evaluation of the Modified VISTA Technique Using ALB-PRF vs CTG in the Treatment of Multiple Miller Class III Recessions
Clinical Evaluation of the Modified VISTA Technique (M-VISTA )Using Albumin-platelet Rich Fibrin (Alb-PRF) Versus Connective Tissue Graft (CTG)in the Treatment of Multiple Miler Class III RT2 Recessions A Randomized Clinical Trial
Sponsor
Cairo University
Enrollment
26 participants
Start Date
Apr 20, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
treatment of miller class III RT2 gingival recession using modified vista technique using connective tissue graft vs albumin PRF
Eligibility
Min Age: 18 YearsMax Age: 60 Years
Inclusion Criteria1
- years old good oral hygiene
Exclusion Criteria1
- smokers patients with poor oral hygiene
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERConnective tissue graft
regenerative properties
BIOLOGICALALB-PRF
regenerative properties
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06643507
Related Trials
Impact of Root Surface Conditioning With Erythritol Air Polishing and Hand Instrumentation on Recession Coverage Using the Modified Tunnel Technique and Subepithelial Connective Tissue Graft.
NCT074030061 location
Gingival Recessions in Orthodontically Treated and Untreated Adult Patients
NCT074455551 location
A Novel Volume Stable Matrix for Gingival Recession Coverage at Teeth
NCT074374171 location
Free Mucogingival Graft for Isolated Root Coverage
NCT058512481 location
Changes in Soft Tissue Thickness Following Multiple Coronally Advanced Tunnel (MCAT) vs Vestibular Incision Subperiosteal Tunnel Access (VISTA)
NCT072002581 location